Dr. Arul Chinnaiyan, a researcher at the Comprehensive Cancer Center, will be presented the American Association for Cancer Research Award for Outstanding Achievement in Cancer Research at the group’s annual meeting April 12-16 in San Diego.
Chinnaiyan, director of the Michigan Center for Translational Pathology and S.P. Hicks Endowed Professor of Pathology, focuses his research on using genomic, proteomic, and bioinformatic approaches to better understand the biology of cancer and to uncover biomarkers. The work of his laboratory has implications for the future of diagnosis and therapy for prostate and many other types of cancer.
“Mapping of the human genome was only the beginning. Equipped with the comprehensive analysis of the human genome, we can now systematically examine the blueprint of disease at the molecular level. This essential knowledge may lead to better diagnostic tests and promising new treatments for cancer and other illnesses,” says Chinnaiyan, professor of pathology and urology at the Medical School and an investigator at the Howard Hughes Medical Institute.
The Outstanding Achievement in Cancer Research award is one in a series of honors given annually by the AACR, the world’s oldest and largest professional organization representing cancer scientists from the United States and nearly 70 other countries. Awards honor outstanding accomplishments in basic cancer research, clinical care, therapeutics and prevention. Each recipient presents an educational lecture at the AACR annual meeting.
For more information on Chinnaiyan’s research go to www.med.umich.edu/mctp.
